Targeting KMA seeks to spare normal immunoglobulin-producing plasma cells, differentiating from BCMA-directed CAR T approaches associated with broader plasma-cell depletion and infectious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results